Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells

Published:2007-02 Issue:2 Volume:18 Page:161-170
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Lin Che-Pin,Liu Jean-Dean,Chow Jyh-Ming,Liu Chien-Ru,Eugene Liu Hsingjin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference47 articles.

1. Molecular pathogenesis of human hepatocellular carcinoma;Thorgeirsson;Nat Genet,2002

2. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein;Yu;J Hepatol,1999

3. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the c-myc protooncogene at transcriptional level;Balsano;Biochem Biophys Res Commun,1991

4. Multiple chromosomal abnormalities in human liver (pre)neoplasia;Raidl;J Hepatol,2004

5. High-throughput tissue microarray analysis of c-myc activation in chronic liver disease and hepatocellular carcinoma;Chan;Hum Pathol,2004

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of restenosis after balloon injury in rabbit vessels by integrin αvβ3-targeted 10058-F4 nanoparticles;Journal of Experimental Nanoscience;2024-08-15

2. Targeting Metabolic–Redox Nexus to Regulate Drug Resistance: From Mechanism to Tumor Therapy;Antioxidants;2024-07-10

3. C-Myc inhibition intensified the anti-leukemic properties of Imatinib in chronic myeloid leukemia cells;Molecular Biology Reports;2023-11-04

4. MYC in liver cancer: mechanisms and targeted therapy opportunities;Oncogene;2023-10-13

5. Identification of IKZF1 genetic mutations as new molecular subtypes in acute myeloid leukaemia;Clinical and Translational Medicine;2023-06